Jenburkt Pharmaceuticals Limited (JENBURPH.BO)
INR 1092.3
(4.74%)
INR 1092.3
(4.74%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.1 Billion INR | -34.8% |
| 2022 | 1.02 Billion INR | 11.64% |
| 2021 | 916.69 Million INR | 16.89% |
| 2020 | 784.25 Million INR | -8.07% |
| 2019 | 853.07 Million INR | -0.32% |
| 2018 | 855.85 Million INR | 6.7% |
| 2017 | 802.08 Million INR | 10.91% |
| 2016 | 723.16 Million INR | 12.89% |
| 2015 | 640.58 Million INR | 11.33% |
| 2014 | 575.38 Million INR | 16.89% |
| 2013 | 492.24 Million INR | 10.22% |
| 2012 | 446.6 Million INR | 16.32% |
| 2011 | 383.94 Million INR | 9.0% |
| 2010 | 352.23 Million INR | 21.22% |
| 2009 | 290.57 Million INR | 22.86% |
| 2008 | 236.51 Million INR | 9.01% |
| 2007 | 216.97 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 150.59 Million INR | -23.31% |
| 2023 Q3 | 282.05 Million INR | -3.02% |
| 2023 FY | 667.27 Million INR | -34.8% |
| 2023 Q1 | 236.32 Million INR | -4.22% |
| 2023 Q2 | 290.84 Million INR | 23.07% |
| 2023 Q4 | 196.36 Million INR | -30.38% |
| 2022 Q4 | 246.75 Million INR | -6.75% |
| 2022 Q1 | 239.87 Million INR | 19.51% |
| 2022 Q3 | 264.6 Million INR | -2.76% |
| 2022 FY | 1.02 Billion INR | 11.64% |
| 2022 Q2 | 272.1 Million INR | 13.44% |
| 2021 FY | 916.69 Million INR | 16.89% |
| 2021 Q1 | 201 Million INR | -7.37% |
| 2021 Q2 | 265.39 Million INR | 32.03% |
| 2021 Q3 | 249.56 Million INR | -5.96% |
| 2021 Q4 | 200.72 Million INR | -19.57% |
| 2020 FY | 784.25 Million INR | -8.07% |
| 2020 Q1 | 131.79 Million INR | -41.08% |
| 2020 Q2 | 213.16 Million INR | 61.73% |
| 2020 Q3 | 226.54 Million INR | 6.28% |
| 2020 Q4 | 217 Million INR | -4.21% |
| 2019 Q1 | 141.13 Million INR | -43.05% |
| 2019 Q4 | 223.69 Million INR | -7.88% |
| 2019 Q2 | 245.41 Million INR | 73.89% |
| 2019 Q3 | 242.82 Million INR | -1.06% |
| 2019 FY | 853.07 Million INR | -0.32% |
| 2018 Q2 | 220.69 Million INR | 36.55% |
| 2018 FY | 855.85 Million INR | 6.7% |
| 2018 Q4 | 247.8 Million INR | 9.79% |
| 2018 Q1 | 161.63 Million INR | -12.99% |
| 2018 Q3 | 225.71 Million INR | 2.27% |
| 2017 Q3 | 209.5 Million INR | -22.01% |
| 2017 Q4 | 185.76 Million INR | -11.33% |
| 2017 Q2 | 268.63 Million INR | 152.02% |
| 2017 Q1 | 106.58 Million INR | -46.86% |
| 2017 FY | 802.08 Million INR | 10.91% |
| 2016 Q1 | 150.78 Million INR | 8.29% |
| 2016 Q4 | 200.59 Million INR | 13.19% |
| 2016 Q3 | 177.22 Million INR | -10.88% |
| 2016 Q2 | 198.86 Million INR | 31.89% |
| 2016 FY | 723.16 Million INR | 12.89% |
| 2015 Q4 | 139.24 Million INR | -18.91% |
| 2015 FY | 640.58 Million INR | 11.33% |
| 2015 Q1 | 155.53 Million INR | 12.64% |
| 2015 Q2 | 174.08 Million INR | 11.92% |
| 2015 Q3 | 171.72 Million INR | -1.35% |
| 2014 Q1 | 134.83 Million INR | 24.88% |
| 2014 FY | 575.38 Million INR | 16.89% |
| 2014 Q3 | 149.23 Million INR | -2.62% |
| 2014 Q4 | 138.07 Million INR | -7.47% |
| 2014 Q2 | 153.25 Million INR | 13.66% |
| 2013 Q4 | 107.97 Million INR | -20.53% |
| 2013 FY | 492.24 Million INR | 10.22% |
| 2013 Q3 | 135.87 Million INR | 5.22% |
| 2013 Q2 | 129.12 Million INR | 11.51% |
| 2013 Q1 | 115.79 Million INR | 18.54% |
| 2012 Q2 | 130.28 Million INR | 30.0% |
| 2012 Q1 | 100.21 Million INR | -4.34% |
| 2012 FY | 446.6 Million INR | 16.32% |
| 2012 Q4 | 97.67 Million INR | -17.52% |
| 2012 Q3 | 118.42 Million INR | -9.1% |
| 2011 Q3 | 94.49 Million INR | 0.0% |
| 2011 Q4 | 104.76 Million INR | 10.86% |
| 2011 FY | 383.94 Million INR | 9.0% |
| 2010 FY | 352.23 Million INR | 21.22% |
| 2009 FY | 290.57 Million INR | 22.86% |
| 2008 FY | 236.51 Million INR | 9.01% |
| 2007 FY | 216.97 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| DECIPHER LABS LIMITED | 331.34 Million INR | -234.489% |
| Gujarat Themis Biosyn Limited | 1.28 Billion INR | 13.559% |
| Ishita Drugs and Industries Limited | 38.94 Million INR | -2746.088% |
| MedPlus Health Services Limited | 12.33 Billion INR | 91.013% |
| ANG Lifesciences India Limited | 232.73 Million INR | -376.209% |
| Add-Shop E-Retail Limited | 224.09 Million INR | -394.56% |
| Bacil Pharma Limited | -19.95 Thousand INR | 5555463.409% |
| BDH Industries Limited | 175.55 Million INR | -531.309% |
| Beryl Drugs Limited | 108.5 Million INR | -921.442% |
| Cian Healthcare Limited | 113.16 Million INR | -879.336% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | -5929.241% |
| Concord Drugs Limited | 116.7 Million INR | -849.663% |
| Deccan Health Care Limited | 221.57 Million INR | -400.199% |
| Gujarat Terce Laboratories Limited | 141.4 Million INR | -683.751% |
| Hindustan Bio Sciences Limited | 3.14 Million INR | -35193.299% |
| KIMIA BIOSCIENCES LIMITED | 111.76 Million INR | -891.639% |
| Kwality Pharmaceuticals Limited | 1.43 Billion INR | 22.874% |
| Makers Laboratories Limited | 308.54 Million INR | -259.199% |
| Medi-Caps Limited | 68.09 Million INR | -1527.643% |
| Panchsheel Organics Limited | 356.44 Million INR | -210.927% |
| Parmax Pharma Limited | 99.31 Million INR | -1015.916% |
| Parnax Lab Limited | 552.1 Million INR | -100.739% |
| Patidar Buildcon Limited | -26 Thousand INR | 4262773.077% |
| Phaarmasia Limited | 38.89 Million INR | -2749.82% |
| Vikram Thermo (India) Limited | 443.73 Million INR | -149.766% |
| Sanjivani Paranteral Limited. | 208.87 Million INR | -430.595% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 273079.064% |
| Smruthi Organics Limited | 324.76 Million INR | -241.265% |
| Source Natural Foods and Herbal Supplements Limited | 66.01 Million INR | -1578.93% |
| SUDARSHAN PHARMA INDUSTRIES LI | 361.76 Million INR | -206.354% |
| Trident Lifeline Limited | 119.08 Million INR | -830.699% |
| Transchem Limited | -8.96 Million INR | 12461.085% |
| Trinity League India Limited | 1.23 Million INR | -89859.01% |
| Tyche Industries Limited | 290.84 Million INR | -281.059% |
| Vista Pharmaceuticals Limited | 10.02 Million INR | -10960.828% |
| Vivanza Biosciences Limited | 19.38 Million INR | -5616.692% |
| PRAVEG LIMITED | 266.99 Million INR | -315.101% |
| Sastasundar Ventures Limited | 1.19 Billion INR | 7.606% |
| Sunil Healthcare Limited | 247.86 Million INR | -347.135% |
| Syschem (India) Limited | 569.04 Million INR | -94.763% |
| Zenith Healthcare Limited | 46.17 Million INR | -2300.258% |
| Zenlabs Ethica Limited | 147.75 Million INR | -650.095% |
| Mercury Laboratories Limited | 279.39 Million INR | -296.684% |
| SHELTER PHARMA LIMITED | 110.97 Million INR | -898.725% |
| Vasundhara Rasayans Limited | 207.68 Million INR | -433.647% |
| Bharat Immunologicals & Biologicals Corporation Limited | -146.67 Million INR | 855.608% |
| Roopa Industries Limited | 72.95 Million INR | -1419.19% |
| PANJON LTD. | 33.77 Million INR | -3181.018% |
| Pharmaids Pharmaceuticals Limited | -72.81 Million INR | 1622.007% |
| TIAAN CONSUMER LIMITED | -17.81 Million INR | 6322.88% |
| Anuh Pharma Limited | 1.6 Billion INR | 30.88% |
| Crestchem Limited | 51.53 Million INR | -2050.457% |
| Emmessar Biotech & Nutrition Limited | -7.43 Million INR | 15010.467% |
| Sandu Pharmaceuticals Limited | 347.1 Million INR | -219.297% |
| Fredun Pharmaceuticals Limited | 724.71 Million INR | -52.929% |
| Trimurthi Limited | 1.95 Million INR | -56706.509% |
| Shukra Pharmaceuticals Limited | 300.38 Million INR | -268.957% |
| Norris Medicines Limited | 29.36 Million INR | -3674.549% |
| Veerhealth Care Limited | 49.57 Million INR | -2135.638% |
| Lactose (India) Limited | 230.3 Million INR | -381.221% |
| OXYGENTA PHARMACEUTICAL LIMITE | -99.79 Million INR | 1210.605% |
| Ambalal Sarabhai Enterprises Limited | 717.63 Million INR | -54.436% |
| Gennex Laboratories Limited | 276.99 Million INR | -300.114% |
| Denis Chem Lab Limited | 596.24 Million INR | -85.879% |
| Colinz Laboratories Limited | 16.35 Million INR | -6676.49% |
| Godavari Drugs Limited | 359.01 Million INR | -208.709% |
| Zenotech Laboratories Limited | 337.19 Million INR | -228.678% |
| Shree Ganesh Remedies Limited | 674.17 Million INR | -64.392% |
| Bharat Parenterals Limited | 989.46 Million INR | -12.009% |
| Coral Laboratories Limited | 332.39 Million INR | -233.43% |
| Evoq Remedies Limited | 47.43 Million INR | -2236.499% |
| Kerala Ayurveda Limited | 447.69 Million INR | -147.558% |
| KOBO BIOTECH LIMITED | -40.71 Million INR | 2822.147% |
| Natural Capsules Limited | 557.1 Million INR | -98.94% |
| Auro Laboratories Limited | 249.39 Million INR | -344.402% |